These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 30099503)

  • 1. Mediator Kinase Disruption in MED12-Mutant Uterine Fibroids From Hispanic Women of South Texas.
    Park MJ; Shen H; Kim NH; Gao F; Failor C; Knudtson JF; McLaughlin J; Halder SK; Heikkinen TA; Vahteristo P; Al-Hendy A; Schenken RS; Boyer TG
    J Clin Endocrinol Metab; 2018 Nov; 103(11):4283-4292. PubMed ID: 30099503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oncogenic exon 2 mutations in Mediator subunit MED12 disrupt allosteric activation of cyclin C-CDK8/19.
    Park MJ; Shen H; Spaeth JM; Tolvanen JH; Failor C; Knudtson JF; McLaughlin J; Halder SK; Yang Q; Bulun SE; Al-Hendy A; Schenken RS; Aaltonen LA; Boyer TG
    J Biol Chem; 2018 Mar; 293(13):4870-4882. PubMed ID: 29440396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Uterine leiomyoma-linked MED12 mutations disrupt mediator-associated CDK activity.
    Turunen M; Spaeth JM; Keskitalo S; Park MJ; Kivioja T; Clark AD; Mäkinen N; Gao F; Palin K; Nurkkala H; Vähärautio A; Aavikko M; Kämpjärvi K; Vahteristo P; Kim CA; Aaltonen LA; Varjosalo M; Taipale J; Boyer TG
    Cell Rep; 2014 May; 7(3):654-60. PubMed ID: 24746821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RISING STARS: Role of MED12 mutation in the pathogenesis of uterine fibroids.
    Ishikawa H; Kobayashi T; Kaneko M; Saito Y; Shozu M; Koga K
    J Mol Endocrinol; 2023 Nov; 71(4):. PubMed ID: 37668348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aberrant R-loop-induced replication stress in MED12-mutant uterine fibroids.
    Muralimanoharan S; Shamby R; Stansbury N; Schenken R; de la Pena Avalos B; Javanmardi S; Dray E; Sung P; Boyer TG
    Sci Rep; 2022 Apr; 12(1):6169. PubMed ID: 35418189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Somatic MED12 mutations in prostate cancer and uterine leiomyomas promote tumorigenesis through distinct mechanisms.
    Kämpjärvi K; Kim NH; Keskitalo S; Clark AD; von Nandelstadh P; Turunen M; Heikkinen T; Park MJ; Mäkinen N; Kivinummi K; Lintula S; Hotakainen K; Nevanlinna H; Hokland P; Böhling T; Bützow R; Böhm J; Mecklin JP; Järvinen H; Kontro M; Visakorpi T; Taipale J; Varjosalo M; Boyer TG; Vahteristo P
    Prostate; 2016 Jan; 76(1):22-31. PubMed ID: 26383637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutation analysis of components of the Mediator kinase module in MED12 mutation-negative uterine leiomyomas.
    Mäkinen N; Heinonen HR; Sjöberg J; Taipale J; Vahteristo P; Aaltonen LA
    Br J Cancer; 2014 Apr; 110(9):2246-9. PubMed ID: 24642626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutations in Exon 1 highlight the role of MED12 in uterine leiomyomas.
    Kämpjärvi K; Park MJ; Mehine M; Kim NH; Clark AD; Bützow R; Böhling T; Böhm J; Mecklin JP; Järvinen H; Tomlinson IP; van der Spuy ZM; Sjöberg J; Boyer TG; Vahteristo P
    Hum Mutat; 2014 Sep; 35(9):1136-41. PubMed ID: 24980722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and characterization of the mediator kinase-dependent myometrial stem cell phosphoproteome.
    Barron L; Khadka S; Schenken R; He L; Blenis J; Blagg J; Chen SF; Tsai KL; Boyer TG
    F S Sci; 2021 Nov; 2(4):383-395. PubMed ID: 35559861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MED12 exon 2 mutations in histopathological uterine leiomyoma variants.
    Mäkinen N; Vahteristo P; Kämpjärvi K; Arola J; Bützow R; Aaltonen LA
    Eur J Hum Genet; 2013 Nov; 21(11):1300-3. PubMed ID: 23443020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel MED12 gene somatic mutations in women from the Southern United States with symptomatic uterine fibroids.
    Halder SK; Laknaur A; Miller J; Layman LC; Diamond M; Al-Hendy A
    Mol Genet Genomics; 2015 Apr; 290(2):505-11. PubMed ID: 25325994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Highly heterogeneous genomic landscape of uterine leiomyomas by whole exome sequencing and genome-wide arrays.
    Yatsenko SA; Mittal P; Wood-Trageser MA; Jones MW; Surti U; Edwards RP; Sood AK; Rajkovic A
    Fertil Steril; 2017 Feb; 107(2):457-466.e9. PubMed ID: 27889101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclin-dependent kinase 8 is an independent prognosticator in uterine leiomyosarcoma.
    Yasutake N; Iwasaki T; Yamamoto H; Sonoda K; Kodama K; Okugawa K; Asanoma K; Yahata H; Kato K; Oda Y
    Pathol Res Pract; 2022 Jul; 235():153920. PubMed ID: 35605413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MED12 somatic mutations encompassing exon 2 associated with benign breast fibroadenomas and not breast carcinoma in Indian women.
    Darooei M; Khan F; Rehan M; Zubeda S; Jeyashanker E; Annapurna S; Shah A; Maddali S; Hasan Q
    J Cell Biochem; 2019 Jan; 120(1):182-191. PubMed ID: 30230586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Guizhi Fuling Capsule inhibits uterine fibroids growth by modulating Med12-mediated Wnt/β-Catenin signaling pathway.
    Chen L; Chen H; Yang Q; Jiang Y; Liu L; Yu H; Chen Y; Li J; Chen N; Wang H; Wang Q
    J Ethnopharmacol; 2022 May; 290():115115. PubMed ID: 35181487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutational analysis of MED12 exon 2 in uterine leiomyoma and other common tumors.
    Je EM; Kim MR; Min KO; Yoo NJ; Lee SH
    Int J Cancer; 2012 Sep; 131(6):E1044-7. PubMed ID: 22532225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Introduction of Somatic Mutation in MED12 Induces Wnt4/β-Catenin and Disrupts Autophagy in Human Uterine Myometrial Cell.
    El Andaloussi A; Al-Hendy A; Ismail N; Boyer TG; Halder SK
    Reprod Sci; 2020 Mar; 27(3):823-832. PubMed ID: 32046450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MED12 mutation frequency in unselected sporadic uterine leiomyomas.
    Heinonen HR; Sarvilinna NS; Sjöberg J; Kämpjärvi K; Pitkänen E; Vahteristo P; Mäkinen N; Aaltonen LA
    Fertil Steril; 2014 Oct; 102(4):1137-42. PubMed ID: 25108465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MED12, the mediator complex subunit 12 gene, is mutated at high frequency in uterine leiomyomas.
    Mäkinen N; Mehine M; Tolvanen J; Kaasinen E; Li Y; Lehtonen HJ; Gentile M; Yan J; Enge M; Taipale M; Aavikko M; Katainen R; Virolainen E; Böhling T; Koski TA; Launonen V; Sjöberg J; Taipale J; Vahteristo P; Aaltonen LA
    Science; 2011 Oct; 334(6053):252-5. PubMed ID: 21868628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Catechol-O-methyltransferase Val158Met polymorphism is associated with increased risk of multiple uterine leiomyomas either positive or negative for
    Dzhemlikhanova LK; Efimova OA; Osinovskaya NS; Parfenyev SE; Niauri DA; Sultanov IY; Malysheva OV; Pendina AA; Shved NY; Ivashchenko TE; Yarmolinskaya MI; Kakhiani MI; Gorovaya EA; Tkachenko AN; Baranov VS
    J Clin Pathol; 2017 Mar; 70(3):233-236. PubMed ID: 27491313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.